Archives for August 2022

ECHO VOL 11 | Issue 8

View Issue Larger | Download (PDF)

ASE on the Road

With in-person conferences and meetings back in full swing, ASE has a busy exhibit schedule planned for the remainder of the year.

We always enjoy connecting and catching up with members during conferences and meetings.

Make plans to visit ASE’s booth at these upcoming events:

European Society of Cardiology Congress
August 26-29, 2022
Barcelona, Spain

American Association of Nurse Practitioners
September 15-18, 2022
Anaheim, California

Transcatheter Cardiovascular Therapeutics (TCT) Conference
September 16-19, 2022
Boston, Massachusetts

Heart Failure Society Annual Scientific Meeting
September 30-October 3, 2022
National Harbor, Maryland

American College of Emergency Physicians Scientific Assembly
October 1-4, 2022
San Francisco, California

Society of Critical Care Medicine Critical Care Echocardiography Review Course
November 7-9, 2022
Rosemont, Illinois

The ASE 2022 Scientific Sessions: Online Library is Now Available

The ASE 2022 Scientific Sessions: Online Library is available to purchase in the ASE Learning Hub.

The Library includes unlimited online access for three years to all live, in-person sessions presented in Seattle at the 2022 Scientific Sessions. You won’t want to miss special sessions like Pediatric Echo Jeopardy, ShowCASE, and Women in Echo. The Feigenbaum, Gardin, Kerber, and Edler lectures are all included in the Library.

CME/MOC credits, as well as DIY workshops, Chalk Talks, Learning Labs, and on-demand content, are not included with the Online Library.

ASE Members: Remember to login to the ASE Member Portal receive special reduced pricing.

August JASE—As Always, Much to Savor

The August JASE includes, “Longitudinal Arrhythmic Risk Assessment Based on Ejection Fraction in Patients with Recent-Onset Nonischemic Dilated Cardiomyopathy,” by Giulia De Angelis, MD, Marco Merlo, MD, Giulia Barbati, PhD, Silvia Bertolo, MD, Antonio De Luca, MD, Federica Ramani, MSc, Luigi Adamo, MD, PhD, and Gianfranco Sinagra, MD, FESC.

Dr. De Angelis noted that, “In our study conducted on non-ischemic dilated cardiomyopathy patients, we found that significant improvement in left ventricular ejection fraction (LVEF) occurs up to 24 months after initiation of guideline-directed medical therapy (GDMT). LVEF ≤35% identified patients with an increased risk of life-threatening arrhythmias at 24 months but not at earlier time points. The risk of life-threatening arrhythmias was low in the first six months after initiation of GDMT and remained low in patients who experienced an early reduction in left ventricular diameters in response to GDMT.”

Additional clinical investigations explore echocardiographic risk assessment in moderate aortic stenosis, tricuspid regurgitation and outcomes, left and right atrial structure and function in various diseases, LV diastolic flow characteristics and aneurysm formation in hypertrophic cardiomyopathy, LV strain in myocarditis in children and adolescents, and machine learning to enhance diastolic function assessment in children. A Special Article highlighting the March ASE “Artificial Intelligence Forum: Echo Workflow for the Future,” gives readers much to consider about the exciting future of AI and echo.

Brief research communications and correspondence round out the issue.

The President’s Message from Stephen H. Little, MD, FASE, details ASE’s Advocacy impact and its commitment to caretaking the future of echocardiography on the national level. The continuing education and meeting calendar outlines a multitude of learning options near and far.